Filter
259
Text search:
drug
manufacturing
Featured
Recommendations
24
New Publications
54
Language
Document type
No document type
107
Studies & Reports
59
Guidelines
50
Strategic & Response Plan
17
Manuals
13
Fact sheets
6
Situation Updates
3
Resource Platforms
2
Training Material
1
Brochures
1
Countries / Regions
Ghana
14
Global
13
Kenya
12
India
8
Ethiopia
7
Uganda
6
Zimbabwe
6
South Africa
6
Zambia
5
Tanzania
5
Botswana
5
Western and Central Europe
5
Nigeria
4
Malawi
4
South–East Asia Region
4
Africa
4
Philippines
3
Nepal
3
Eastern Europe
3
Sierra Leone
2
Senegal
2
Rwanda
2
Sudan
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
Syria
1
Cambodia
1
Indonesia
1
Bangladesh
1
Mozambique
1
Ukraine
1
Lesotho
1
Asia
1
Tajikistan
1
Russia
1
Moldova
1
Uzbekistan
1
Vietnam
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
100
Clinical Guidelines
17
Pharmacy & Technologies
14
Key Resources
10
Public Health
8
Women & Child Health
3
Capacity Building
2
Toolboxes
AMR
31
COVID-19
30
Pharmacy
28
HIV
18
TB
18
Mental Health
12
Planetary Health
10
Malaria
5
NTDs
4
NCDs
4
Ebola & Marburg
3
Conflict
3
Rapid Response
3
Specific Hazards
3
Global Health Education
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
2.0 Rapid Response
2
Disability
1
Cholera
1
Polio
1
Refugee
1
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f
...
Globally, approximately 56.8 million people are in need of palliative care
services; 78% of them living in low and middle-income country yet only
about 12% have their needs being met causing great suffering for many.
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting,
...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
The first case of COVID-19 was reported in Mozambique on 22 March 2020. As of 26 May, Mozambique had 194 confirmed cases of COVID-19, of which 168 were locally transmitted. The country’s capital, Maputo, and the province of Cabo Delgado are currently the epicentres of the outbreak in Mozambique, w
...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc
...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
Second Edition
AIDS Medicines and diagnostics services
July 2015
The seventh WHO Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are proven to reduce demand for tobacco.
The report showed that while only 23 countries have implemented ce
...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s
...
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
